Andrew Cornforth, PhD
VICE PRESIDENT OF PROCESS DEVELOPMENT
Dr. Cornforth joined TCR² in 2017 as Vice President of Process Development. He brings over 20 years of cell therapy experience having led process development and manufacturing of multiple cell therapy programs from preclinical through late-stage clinical development. Dr. Cornforth was the Vice President of Manufacturing at AIVITA Biomedical and Director of Manufacturing at Progenitor Cell Therapy where his broad expertise was applied to the development of T cells, dendritic cells and stem cells. He has manufactured patient cell-derived immunotherapies for more than 200 patients. Dr. Cornforth earned his BS in Chemistry and PhD from the University of California at Irvine where he studied cell signaling in prostate cancer apoptosis.